COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss. "These data, together with previously reported Phase III trials, consistently demonstrate clinically significant weight loss and improvements in obesity-related risk factors in people with obesity," chief science officer Mads Krogsgaard ...

Frequent heartburn increases the risk for throat cancer, a new study has found, and over-the-counter antacids may provide protection.    

Switch up the healthy fats in your dressings, baked goods, and more to boost flavor and nutrition By:  Matthew Kadey, R.D. Buttery avocado oil is chockablock in monounsaturated fat, the kind considered to be heart-healthy because of its powers to improve cholesterol numbers. This über fruit oil also supplies lutein, an antioxidant that improves eye health, and the white coats ...

The advice to detect and treat cancers at the first opportunity may not apply to older men with prostate tumors, according to the latest study. With a government-backed group advising that most men no longer need regular screening for prostate cancer with the prostate-specific antigen (PSA) blood test, researchers now say that older men who are diagnosed with the disease ...

HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday. Growing evidence of a link between GSK's Pandemrix vaccine and an increase in narcolepsy, a rare sleep disorder, among children who received it in Europe ...